CMS Medicare Formulary Standards Will Have More “Granularity” Than USP
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Medicare & Medicaid Services expects its reviews of Medicare Rx drug plan formularies to include evaluation of drug choices at the “sub-class” level. The standards will also aim to encourage plans to provide more than the minimum two drugs per formulary class.